Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy

被引：0
|
作者：
Shimpei Tsudaka
Hiromasa Yamamoto
Hiroki Sato
Kuniaki Katsui
Ken Suzawa
Kazuhiko Shien
Kentaroh Miyoshi
Shinji Otani
Mikio Okazaki
Seiichiro Sugimoto
Masaomi Yamane
Katsuyuki Kiura
Susumu Kanazawa
Shinichi Toyooka
机构：
[1] Okayama University Graduate School of Medicine,Departments of General Thoracic Surgery and Breast and Endocrinological Surgery
[2] Dentistry and Pharmaceutical Sciences,Departments of Proton Beam Therapy
[3] Okayama University Graduate School of Medicine,Departments of Hematology, Oncology and Respiratory Medicine
[4] Dentistry and Pharmaceutical Sciences,Departments of Radiology
[5] Okayama University Graduate School of Medicine,Departments of Thoracic Surgery
[6] Dentistry and Pharmaceutical Sciences,Departments of Radiology
[7] Okayama University Graduate School of Medicine,Departments of Allergy and Respiratory Medicine
[8] Dentistry and Pharmaceutical Sciences,Organ Transplant Center
[9] Okayama University Hospital,undefined
[10] Okayama University Hospital,undefined
[11] Okayama University Hospital,undefined
[12] Okayama University Hospital,undefined
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4880 / 4890
页数：10
相关论文
共 50 条
  • [1] Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy
    Tsudaka, Shimpei
    Yamamoto, Hiromasa
    Sato, Hiroki
    Katsui, Kuniaki
    Suzawa, Ken
    Shien, Kazuhiko
    Miyoshi, Kentaroh
    Otani, Shinji
    Okazaki, Mikio
    Sugimoto, Seiichiro
    Yamane, Masaomi
    Kiura, Katsuyuki
    Kanazawa, Susumu
    Toyooka, Shinichi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 4880 - 4890
  • [2] Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Park, Eun Young
    Kim, Yeon-Sil
    Choi, Kyu Hye
    Song, Jin Ho
    Lee, Hyo Chun
    Hong, Sook-Hee
    Kang, Jin-Hyoung
    [J]. RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 166 - 175
  • [3] Initial neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with inoperable locally advanced non-small-cell lung cancer
    Sun, Siyu
    Qu, Yanli
    Wen, Fengyun
    Yu, Hong
    [J]. BIOMARKERS IN MEDICINE, 2020, 14 (14) : 1341 - 1352
  • [4] THE PROGNOSTIC VALUE OF THE NEUTROPHIL-TO-LYMPHOCYTE RATIO IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER AND PULMONARY COMORBIDITIES
    Miron, Oana Tatiana
    Afrasinei, Vlad
    Miron, L.
    Petrariu, F. D.
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2020, 124 (02): : 215 - 224
  • [5] Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
    Bayraktaroglu, Mesut
    Yildiz, Birsen Pinar
    [J]. MEDICINE, 2023, 102 (26) : E34180
  • [6] Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy
    Yin, Xiaoming
    Chen, Haijun
    Sun, Yunchuan
    Xiao, Li
    Lu, Hongling
    Guo, Wei
    Yang, Hongjuan
    Zhou, Jianxi
    Fan, Kui
    Liang, Wei
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Prognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancer
    Kang, Kylie H.
    Efird, Jimmy T.
    Sharma, Neelesh
    Yang, Michael
    Dowlati, Afshin
    Linden, Philip
    Machtay, Mitchell
    Biswas, Tithi
    [J]. FUTURE ONCOLOGY, 2017, 13 (16) : 1405 - 1414
  • [8] Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
    Aya Nakaya
    Takayasu Kurata
    Hiroshige Yoshioka
    Yuki Takeyasu
    Maiko Niki
    Kayoko Kibata
    Naoko Satsutani
    Makoto Ogata
    Takayuki Miyara
    Shosaku Nomura
    [J]. International Journal of Clinical Oncology, 2018, 23 : 634 - 640
  • [9] Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
    Nakaya, Aya
    Kurata, Takayasu
    Yoshioka, Hiroshige
    Takeyasu, Yuki
    Niki, Maiko
    Kibata, Kayoko
    Satsutani, Naoko
    Ogata, Makoto
    Miyara, Takayuki
    Nomura, Shosaku
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (04) : 634 - 640
  • [10] Prognostic Impact of Neutrophil-to-Lymphocyte Ratio (NLR) for Advanced Non-Small Cell Lung Cancer
    Ishihara, M.
    Ochiai, R.
    Haruyama, T.
    Tagami, Y.
    Sakamoto, T.
    Tanzawa, S.
    Honda, T.
    Ota, S.
    Ichikawa, Y.
    Watanabe, K.
    Seki, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S389 - S389
12345